Mounjaro syringes: how the KwikPen works and what the evidence shows

Mounjaro is supplied as a pre-filled KwikPen, not a separate syringe — one pen holds four weekly doses at a single strength.
Each injection goes just under the skin (subcutaneous) at the abdomen, thigh, or upper arm; the pen's design makes the process straightforward.
Needles are attached to the pen cap before each use; rotating injection sites matters for skin health and consistent absorption.
Storage is refrigerated at 2–8 °C; always check the Patient Information Leaflet for the exact permitted room-temperature window before travelling.

Mounjaro does not come in a traditional syringe. It is supplied as a pre-filled KwikPen — each pen contains four weekly doses of tirzepatide, the dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. Clinical trials published in the New England Journal of Medicine showed average body-weight reductions of around 20–21% over 72 weeks at the highest dose, and those results were achieved with the injector pen used at home, once a week. Mounjaro is a prescription-only medicine, so a prescriber must assess whether it is clinically suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The KwikPen in practice: mechanics, injection sites, and what patients actually ask

What SURMOUNT-1 tells us about the injector patients were using

Every participant in SURMOUNT-1 (the landmark tirzepatide weight-management trial) used the same KwikPen format that reaches UK patients today. The trial ran for 72 weeks across more than 2,500 adults and the results (roughly 20–21% average weight loss at 15 mg) were achieved by people self-injecting once a week at home, not in a clinical setting. That context matters: the pen was deliberately designed so that patients could use it reliably without nursing support. The NHS medicines page for tirzepatide confirms the injection method and covers the main safety points clearly.

Treatment starts at 2.5 mg (a tolerability dose that allows the body to adjust) and is titrated in steps by the prescriber, typically every four weeks, up through 5, 7.5, 10, 12.5, and 15 mg. Each pen corresponds to one strength, so patients move to a new pen when their dose changes. There is no measuring, no drawing up of liquid, and no separate plunger to manage.

This design is part of why adherence in the trials held up well. The weekly schedule, combined with a device that requires minimal technique, removes many of the practical barriers that older injectable therapies carried.

How the KwikPen is attached, used, and disposed of

A question our prescribers hear most weeks is whether Mounjaro needs a separate needle or comes ready to inject. The answer is that a needle is attached immediately before each use (it screws onto the pen's tip) and then removed and disposed of in a sharps container straight afterwards. Leaving a needle attached between doses risks contamination and can let air into the mechanism.

The actual injection sequence is short: attach a new needle, prime as instructed in the leaflet, choose a clean injection site, pinch the skin gently if you find that helpful, press the pen against the skin until you hear a click, and hold it in place for around ten seconds. The pen does the rest. No plunger, no manual force. You can find full technique guidance in the Patient Information Leaflet included with your pen, or on the eMC (electronic Medicines Compendium), where the Mounjaro SmPC is published in full.

Rotating between the abdomen, thigh, and upper arm is important. Using the same spot repeatedly can cause skin changes (thickening or lumping) that affect how quickly tirzepatide is absorbed. A simple pattern (left abdomen, right abdomen, left thigh, and so on) makes rotation easy to remember without writing anything down.

Storing the pen and travelling with it

The KwikPen is kept in the fridge between 2 °C and 8 °C. Because Mounjaro is taken once a week, most people keep the current pen in the fridge door and inject on the same day each week, then order the next pen in good time. Detailed guidance on storing Mounjaro covers what to do if the pen warms up, how long a room-temperature window is permitted, and why the pen should never be frozen, the SmPC is the authoritative reference for exact figures and should always be consulted rather than relying on memory.

Travelling is generally straightforward. The pen travels in its original carton; airline rules allow medication in hand luggage with a prescription. A small cool bag with an ice pack keeps the pen within the safe temperature range on longer journeys. For shorter domestic trips where a fridge will be available at the destination, most patients find the transition seamless enough with a little advance planning.

When the pen format matters for your prescriber conversation

Some people ask whether they can switch between pen strengths mid-pack, or use part of one pen and keep the rest. The answer is no, each pen is designed for single-patient use across the four doses at that strength, and each dose uses a fresh needle. Unused doses left in a discarded pen are wasted, which is one reason prescribers give careful thought to timing dose changes at the right point in the pack cycle.

If you are considering Mounjaro for weight management and have practical questions about the pen before you start, that conversation belongs in your clinical consultation. Details such as which injection sites work best for your lifestyle, whether you have any anxiety around needles, or how to handle a missed dose are all things the prescriber will want to cover. Patients based in the East Midlands can also read about how we support people through our Mounjaro service in Nottingham, which explains local access and what to expect from an in-person consultation. For a broader look at how tirzepatide fits into a weight-management plan, the weight-loss treatments overview is a useful starting point.

There are also questions that sit alongside the pen itself, and if you take over-the-counter painkillers regularly, our page on how tirzepatide and aspirin interact addresses one of the more frequent queries we receive. Pricing context is covered separately; if you want to understand what the cost of private treatment typically includes, the Mounjaro cost and access page sets that out plainly. Start your free consultation with our prescribers whenever you are ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions